Immune response towards snake venoms

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 5, 2011, Pages 381-398

  León, Guillermo ^a   Sánchez, Laura ^a   Hernández, Andrés ^a   Villalta, Mauren ^a   Herrera, María ^a   Segura, Álvaro ^a   Estrada, Ricardo ^a   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Antivenoms; Immune response; Immunization; Immunogens; Snake venoms

Indexed keywords

AMINO ACID OXIDASE; BOTHROPS ASPER VENOM; CARDIOTOXIN; CROTALUS DURISSU TERRIFICUS VENOM; DENDROTOXIN; DISINTEGRIN; ECHIS OCELLATUS VENOM; FASCICULIN; IMMUNOLOGICAL ADJUVANT; INTEGRIN; KAPPA NEUROTOXIN; LACHESIS MUTA VENOM; LIPOSOME; METALLOPROTEINASE; NAJA KAOUTHIA VENOM; NEUROTOXIN; OHIOPHAGUS HANNA VENOM; PHOSPHOLIPASE A2; SARAFOTOXIN; SERINE PROTEINASE; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; CROSS REACTION; ENVENOMATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; REVIEW; SNAKEBITE; THROMBOCYTE AGGREGATION INHIBITION;

EID: 80052862269     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811797200605     Document Type: Review

References (271)

1. Meier, J.; Stocker, K.F. Biology and distribution of venomous snakes of medical importance and the composition of snake venoms. In: Handbook of Clinical Toxicology of Animal Venoms and Poisons; Meier, J., White, J., Eds.; CRC Press: Boca Raton, 1995; pp. 367-412.
2. Fry, B.G.; Vidal, N.; Norman, J.A.; Vonk, F.J.; Scheib, H.; Ramjan, S.F.; Kuruppu, S.; Fung, K.; Hedges, S.B.; Richardson, M.K.; Hodgson, W.C.; Ignjatovic, V.; Summerhayes, R; Kochva, E. Early evolution of the venom system in lizards and snakes. Nature, 2006; 439, 584-588.
3. Mackessy, S.P. The field of reptile toxinology. Snakes, lizards, and their venoms In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P., Ed.; CRC Press: Boca Raton, 2009; pp. 3-23.
4. Calvete, J.J.; Suárez, P.; Sanz, L. Snake venomics. Strategy and applications. J. Mass Spectrom., 2007, 42, 1405-1414.
5. Serrano, S.M.T.; Fox, J.W. Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures. Proteomics, 2008, 8, 909-920.
6. Chippaux, JP. Snake-bites: appraisal of the global situation. Bull. World Health Org., 1998, 76, 515-524.
7. Gutiérrez, J.M.; Theakston, R.D.G.; Warrell, D.A. Confronting the neglected problem of snake bite envenoming: The need for a global partnership. PLoS Med, (On Line) 2006, 3(6), 727-731. http://plosmedicine.org/ [Accessed on: 06 June 2006].
8. Gutiérrez, J.M.; Williams, D.; Fan, H.W.; Warrell, D.A. Snakebite envenoming from a global perspective: the need of an integrated approach. Toxicon, 2010, 56, 1223-1235.
9. Kasturiratne, A.; Wickremasinghe, A.R.; de Silva, N.; Gunawardena, N.K.; Pathmeswaran, A.; Premaratna, R.; Savioli, L.; Lallo, D.G.; de Silva, H.J. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med, [On Line] 2008, 5(11), 1591-1604. http://plosmedicine.org/ [Accessed on: 04 November 2008].
10. Warrell, D.A. Envenomings and Their Treatments. In: Clinical features of envenoming from snake bites; Bon, C., Goyffon, M., Eds.; Fondation Marcel Mérieux: Lyon, 1996; pp. 63-76.
11. Ribeiro, L.A.; Puorto, G.; Jorge, M.T. Bites by the colubrid snake Philodryas olfersii: a clinical and epidemiological study of 43 cases. Toxicon, 1999, 37, 943-948.
12. Hill, R.E.; Mackessy, S.P. Characterization of venom (Duvernoy's secretion) from twelve species of colubrid snakes and partial sequence of four venom proteins. Toxicon, 2000, 38, 1663-1687.
13. Peichoto, M.E.; Teibler, P.; Ruíz, R.; Leiva, L.; Acosta, O. Systemic pathological alterations caused by Philodryas patagoniensis colubrid snake venom in rats. Toxicon, 2006, 48, 520-528.
14. Weinstein, S.; Keyler, D. Local envenoming by the Western hognose snake (Heterodon nasicus): A case report and review of medically significant Heterodon bites. Toxicon, 2009, 54, 354-360.
15. Chippaux, J.P.; Goyffon, M. Venoms, antivenoms and immunotherapy. Toxicon, 1998, 36, 823-846.
16. World Health Organization. Rabies and Envenomigs. A Neglected Public Health Geneva, 2007.
17. Theakston, R.; Warrell, D.; Griffiths, E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon, 2003, 41, 541-557.
18. Gutiérrez, J; León, G. Snake Antivenoms. Technological, clinical and public health issues. In Animal Toxins: State of the Art. Perspectives in Health and Biotechnology; de Lima, M.E., Pimenta, A.M.C., Martin-Euclaire, M.F., Zingalli, R.B., Rochat, H., Eds.; Editora UFMG: Belo Horizonte, 2009; pp. 393-421.
19. Lalloo, D.G.; Theakston, R.D.G. Snake antivenoms. J. Toxicol. Clin. Toxicol., 2003, 41, 277-290.
20. World Health Organization. Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins. Geneva, 2010.
21. Schunk, M.; Macallum, G. Applications and optimization of immunization procedures. ILAR J, 2005, 46, 241-257.
22. Delves, P.J.; Roitt, I.M. The immune system. Advances in Immunology. N. Engl. J. Med., 2000, 343, 37-49.
23. Juárez, P.; Sanz, L.; Calvete, J.J. Snake venomics: characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis. Proteomics, 2004, 4, 327-338.
24. Bazaa, A.; Marrakchi, N.; El-Ayeb, M.; Sanz, L.; Calvete, J.J. Snake venomics: comparative analysis of the venoms proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina. Proteomics, 2005, 5, 4223-4235.
25. Calvete, J.J.; Marcinkiewicz, C.; Sanz, L. Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2. J. Proteome Res., 2007, 6, 326-336.
26. Angulo, Y.; Escolano, J.; Lomonte, B.; Gutiérrez, J.M.; Sanz, L.; Calvete, J.J. Snake venomics of Central American pitvipers: clues for rationalizing the distinct envenomation profiles of Atropoides nummifer and Atropoides picadoi. J. Proteome Res., 2008, 7, 708-719.
27. Lomonte, B.; Escolano, J.; Fernández, J.; Sanz, L.; Angulo, Y.; Gutiérrez, J.M.; Calvete, J.J. Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schelegelii. J. Proteome Res., 2008, 7, 2445-2457.
28. Sanz, L.; Escolano, J.; Ferretti, M.; Biscoglio, M.J.; Rivera, E.; Crescenti, E.J.; Angulo, Y.; Lomonte, B.; Gutiérrez, J.M.; Calvete, J.J. Snake venomics of the South and Central American Bushmasters. Comparison of the toxin composition of Lachesis muta gathered form proteomic versus transcriptomic analysis. J. Proteomics, 2008, 71, 46-60.
29. Sanz, L.; Ayvazyan, N.; Calvete, J.J. Snake venomics of the Armenian vipers Macrovipera lebetina obusta and Vipera raddei. J. Proteomics, 2008, 71, 198-209.
30. Alape-Girón, A.; Sanz, L.; Escolano, J.; Flores-Díaz, M.; Madrigal, M.; Sasa, M.; Calvete, J.J. Snake venomics of the lancead pitviper Bothrops asper: geographic, individual and ontogenic variations. J. Proteome Res., 2008, 7, 3556-3571.
31. Gutiérrez, J.M.; Sanz, L.; Escolano, J.; Fernández, J.; Lomonte, B.; Angulo, Y.; Rucavado, A.; Warrell, D.A.; Calvete, J.J. Snake venomics of the lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom. J. Proteome Res., 2008, 7, 4396-4408.
32. Tashima, A.K.; Sanz, L.; Camargo, A.C.; Serrano, S.M.; Calvete, J.J. Snake venomics of the Brazilian pitvipers Bothrops cotiara and Bothrops fonsecai. Identification of taxonomy markers. J. Proteomics, 2008, 71, 473-485.
33. Calvete, J.J.; Borges, A.; Segura, A.; Flores-Díaz, M.; Alape-Girón, A.; Gutiérrez, J.M.; Diez, N.; De Sousa, L.; Kiriakos, D.; Sánchez, E.; Faks, J.G.; Escolano, J.; Sanz, L. Snake venomics and antivenomics of Bothrops colombiensis, a medically important pitviper of the Bothrops atrox-asper complex endemic to Venezuela: Contributing to its taxonomy and snakebite management. J. Proteomics, 2009, 72, 227-240.
34. Nuñez, V.; Cid, P.; Sanz, L.; de la Torre, P.; Angulo, Y.; Lomonte, B.; Gutiérrez, J.M.; Calvete, J.J. Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Perú and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism. J. Proteomics, 2009, 73, 57-78.
35. Valente, R.H.; Guimarães, P.R.; Junqueira, M.; Neves-Ferreira, A.G.; Soares, M.R.; Chapeaurouge, A.; Trugilho, M.R.; León, I.R.; Rocha, S.L.; Oliveira-Carvalho, A.L.; Wermelinger, L.S.; Dutra, D.L.; Leão, L.I.; Junqueira-de-Azevedo, I.L.; Ho, P.L.; Zingali, R.B.; Perales, J.; Domont, G.B. Bothrops insularis venomics: a proteomic analysis supported by transcriptomic-generated sequence data. J. Proteomics, 2009, 72, 241-255.
36. Calvete, J.J.; Fasoli, E.; Sanz, L.; Boschetti, E.; Righetti, P.G. Exploring the venom proteome of the western diamondback rattlesnake, Crotalus atrox, via snake venomics and combinatorial peptide ligand library approaches. J. Proteome Res., 2009, 8, 3055-3067.
37. Wagstaff, S.C.; Sanz, L.; Juárez, P.; Harrison, R.A.; Calvete, J.J. Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus. J. Proteomics, 2009, 71, 609-623.
38. Risch, M.; Georgieva, D.; von Bergen, M.; Jehmlich, N.; Genov, N.; Arni, R.K.; Betzel, C. Snake venomics of the Siamese Russell's viper (Daboia russelli siamensis). Relation to pharmacological activities. J. Proteomics, 2009, 72, 256-269.
39. Olamendi-Portugal, T.; Batista, C.V.F.; Restano, R.R.; Pando, V.; Villa-Hernández, O.; Zavaleta-Matínez-Vargas, A.; Salas-Arruz, M.C.; Rodríguez de la Vega, R.C.; Becerri, B.; Possani, L.D. Proteomic analysis of the venom from the fish eating coral snake Micrurus surinamensis: Novel toxins, their functions and phylogeny. Proteomics, 2008, 8, 1919-1932.
40. Li, S.; Wang, J.; Zhang, X.; Ren, Y.; Wang, N.; Zhao, K.; Chen, X.; Zhao, C.; Li, X.; Shao, J.; Yin, J.; West, M.B.; Xu, N.; Liu, S. Proteomic characterization of two snake venoms: Naja naja atra and Agkistrodon halys. Biochem. J., 2004, 384, 119-127.
41. Ching, A.T.; Rocha, M.M.; Paes-Leme, A.F.; Pimenta, D.C.; de Fátima de Furtado, M.; Serrano, S.M.; Ho, P.L.; Junqueira-de-Azevedo, I.L. Some aspects of the venom proteome of the Colubridae snake Philodryas olfersii revealed from a Duvernoýs (venom) gland transcriptome. FEBS Lett., 2006, 580, 4417-4422.
42. Calvete, J.J.; Sanz, L.; Angulo, Y.; Lomonte, B.; Gutiérrez, J.M. Venoms, venomics and antivenomics. FEBS Lett., 2009, 583, 1736-1743.
43. Tan, N.; Saifuddin, N. Isolation and characterization of a hemorrhagin from the venom of Ophiophagus hannah (king cobra). Toxicon, 1990, 28, 385-392.
44. Ovadia, M. Isolation and characterization of a hemorrhagic factor from the venom of the snake Atractaspis engeddensis (Atractaspididae). Toxicon, 1987, 25, 621-630.
45. Fox, J.W.; Serrano, S.M. Timeline of key events in snake venom metalloproteinase research. J. Proteomics, 2009, 72, 200-209.
46. Fox, J.W.; Serrano, S.M.T. Snake venom metalloproteinases. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P., Ed.; CRC Press: Boca Raton, 2009; pp. 95-113.
47. Gutiérrez, J.M.; Rucavado, A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie, 2000, 82, 841-850.
48. Gutiérrez, J.M.; Rucavado, A.; Escalante, T.; Díaz, C. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon, 2005, 45, 997-1011.
49. Gutiérrez, J.M.; Rucavado, A.; Escalante, T. Snake venom metalloproteinases. Biological roles and participation in the pathophysiology of envenomation. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P. Ed.; CRC Press: Boca Raton, 2009, pp. 115-138.
50. Franceschi, A.; Rucavado, A.; Mora, N.; Gutiérrez, J.M. Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Toxicon, 2000, 38, 63-77.
51. Escalante, T.; Nuñez, J.; Moura da Silva, A.; Rucavado, A.; Theakston, R.D.; Gutiérrez, J.M. Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom. Toxicol. Appl. Pharmacol., 2003, 193, 17-28.
52. Moura-da-Silva, A.M.; Serrano, S.M.T.; Fox, J.W.; Gutiérrez, J.M. Snake venom metalloproteinases. Structure, function and effects on snakebite pathology. In: Animal Toxins: State of the Art. Perspectives in Health and Biotechnology; de Lima, M.E., Pimenta, A.M.C., Martin-Euclaire, M.F., Zingalli, R.B., Rochat, H., Eds.; Editora UFMG: Belo Horizonte, 2009; pp. 525-546.
53. Stocker, W.; Bode, W. Structural features of a superfamily of zincendopeptidases: the metzincins. Curr. Op. Struct. Biol., 1995, 5, 383-390.
54. Swenson, S.; Markland, F.S. Snake venom fibrin(ogen)olytic enzymes. Toxicon, 2005, 45, 1021-1039.
55. Teixeira, C.F.P.; Fernandes, C.M.; Zuliani, J.P.; Zamunér, S.R. Inflammatory effects of snake venom metalloproteinases. Mem. Inst. Oswaldo Cruz, 2005, 100, 181-184.
56. Weissenberg, S.; Ovadia, M.; Kochva, E. Species specific sensitivity towards the hemorrhagin of Ophiophagus Hannah (Elapidae). Toxicon, 1987, 25, 475-481.
57. Gutiérrez, J.M.; Sanz, L.; Flores-Díaz, M.; Figueroa, L.; Madrigal, M.; Herrera, M.; Villalta, M.; León, G.; Estrada, R.; Borges, A.; Alape-Girón, A.; Calvete, J.J. Impact of regional variation in Bothrops asper venom on the design of antivenoms: Integrating antivenomics and neutralization approaches. J. Proteome Res., 2009, 9, 564-577.
58. Braud, S.; Bon, C.; Wisner, A. Snake venom proteins acting on hemostasis. Biochimie, 2000, 82, 851-859.
59. Jin, Y.; Lee, W.H.; Zhang, Y. Molecular cloning of serine proteases from elapids snake venoms. Toxicon, 2007, 49, 1200-1207.
60. Paes-Leme, A.F.; Prezoteo, B.C.; Yamashiro, E.T.; Bertholim, L.; Tashima, A.K.; Klitzke, C.F.; Camargo, A.C.; Serrano, S.M. Bothrops protease A, a unique highly glycosilated serine proteinase, is a potent, specific fibrinogenolytic agent. J. Thromb. Haemost., 2008, 6, 1363-1372.
61. Markland, F.S. Snake venoms and the hemostatic system. Toxicon, 1998, 36, 1749-1800.
62. Matsui, T.; Fujimura, Y.; Titani, K. Snake venom proteases afecting hemostasis and thrombosis. Biochim. Biophys. Acta, 2000, 1477, 146-156.
63. Pirkle, H.; Markland, F.S.; Theodor, I. Thrombin-like enzymes of snake venom: actions on prothrombin. Thromb. Res., 1976, 8, 619-627.
64. Komori, Y.; Nikai, T.; Sugihara, H. Biochemical and physiological studies on a kallikrein-like enzyme from the venom of Crotalus viridis viridis (Prairie rattlesnake). Biochim. Biophys. Acta, 1988, 967, 92-102.
65. Iwanaga, S.; Oshima, G.; Suzuki, T. Proteinases from the venom Agkistrodon halys blomhoffii. Meth. Enzymol., 1976, 45, 459-468.
66. Phillips, D.J.; Swenson, S.D.; Markland, F.S. Thrombin-like snake venom serine proteinases. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P. Ed.; CRC Press: Boca Raton, 2009, pp. 139-154.
67. Kini, R.M. The intriguing world of prothrombin activators from snake venoms. Toxicon, 2005, 45, 1133-1145.
68. Doley, R.; Zhou, X.; Kini, R.M. Snake venom phospholipase A2 enzymes. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P., Ed.; CRC Press: Boca Raton, 2009; pp. 173-205.
69. Arni, R.K.; Ward, R.J. Phospholipase A2: A structural review. Toxicon, 1996, 34, 827-841.
70. Magro, A.J.; Murakami, M.T.; Marcussi, S.; Soares, A.M.; Arni, R.K.; Fontes, M.R. Crystal structure of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 in the monomeric and dimeric states: insights into its oligomeric state. Biochem. Biophys. Res. Comm., 2004, 323, 24-31.
71. Lomonte, B.; Angulo, Y.; Sasa, M.; Gutiérrez, J.M. The phospholipase A2 homologues of snake venoms: Biological activities and their posible adaptive role. Prot. Pept. Letters, 2009, 16, 860-876.
72. Fraenkel-Conrat, H.; Singer, B. Fractionation and Composition of Crotoxin. Arch. Biochem. Biophys., 1956, 60, 64-73.
73. Tsai, I.H.; Lu, P.J.; Wang, Y.M.; Ho, C.L.; Liaw, L.L. Molecular cloning and characterization of a neurotoxic phospholipase A2 from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Biochem. J., 1995, 311, 895-900.
74. Tsai, I.H.; Lu, P.J.; Su, J.C. Two types of Russelĺs viper revealed by variation in phospholipases A2 from venom of the subspecies. Toxicon, 1996, 34, 99-109.
75. Bon, C. Multicomponent neurotoxic phospholipases A2. In: Venom Phospholipase A2 Enzymes. Structure, Function and Mechanism; Kini, R.M. Ed.; Wiley: Chichester, 1997, pp. 269-85.
76. Kini, R.M. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon, 2003, 42, 827-840.
77. Kuruppu S, Smith AI, Isbister GK, Hodgson, W.C. Neurotoxins from Australo-Papuan elapids: a biochemical and pharmacological perspective. Crit. Rev. Toxicol. 2008, 38, 73-86.
78. Tsai, I.H.; Hseu, M.J. Snake venom neurotoxic phospholipases A2. In Animal Toxins: State of the Art. Perspectives in Health and Biotechnology; de Lima, M.E., Pimenta, A.M.C., Martin-Euclaire, M.F., Zingalli, R.B., Rochat, H., Eds.; Editora UFMG: Belo Horizonte, 2009; pp. 481-494.
79. Du, K.Y.; Clement, K.J. Snake venom L-amino acid oxidases. Toxicon, 2002, 40, 659-665.
80. Ponnudurai, G.; Chung, M.; Tan, N.H. Purificaction and properties of the L-amino acid oxidase from Malayan pit viper (Calloselasma rhodostoma) venom. Arch. Biochem. Biophys., 1994, 113, 373-378.
81. Wei, J.F.; Yang, H.W.; Wei, X.L.; Qiao, L.Y.; Wang, W.Y.; He, S.H. Purification, characterization and biological activities of the L-amino acid oxidase from Bungarus fasciatus snake venom. Toxicon, 2009, 54, 262-271.
82. Zhong, S.R.; Jin, Y.; Wu, J.B.; Jia, Y.H.; Xu, G.L.; Wang, G.C.; Xiong, Y.L.; Lu, Q.M. Purification and characterization of a new L-amino acid oxidase from Daboia russellii siamensis venom. Toxicon, 2009, 54, 763-771.
83. Suhr, S.M.; Kim, D.S. Identification of the snake venom substance that induces apoptosis. Biochem. Biophys. Res. Comm., 1996, 224, 134-139.
84. Stiles, B.G.; Sexton, F.W.; Weinstein, S.A. Antibacterial effects of different snake venoms: purification and characterization of antibacterial proteins from Pseudechis australis (Australian King Brown or Mulga snake) venom. Toxicon, 1991, 29, 1129-1141.
85. Ali, S.A.; Stoeva, S.; Abbasi, A.; Alam, J.M.; Kayed, R.; Faigle, M.; Neumeister, B.; Voelter, W. Isolation, structural and functional characterization of an apoptosis-inducing L-amino acid oxidase from Leaf Nosed Viper (Eristocophis macmahoni) snake venom. Arch. Biochem. Biophys., 2000, 384, 216-226.
86. Calvete, J.J.; Moreno-Murciano, M.P.; Sanz, L.; Jürgens, M.; Schrader, M.; Raida, M.; Benjamín, D.C.; Fox, J.W. The disulfide bond pattern of catrocollastatin C a disintegrin-like/cysteine-rich protein isolated from Crotalus atrox venom. Protein Sci., 2000, 9, 1365-1373.
87. Calvete, J.J.; Marcinkiewicz, C.; Monleón, D.; Esteve, V.; Celda, B.; Juárez, P.; Sanz, L. Snake venom disintegrins: evolution of structure and function. Toxicon, 2005, 45, 1063-1074.
88. Calvete, J.J.; Moreno-Murciano, M.P.; Theakston, R.D.G.; Kisile, D.G.; Marcinkiewicz, C. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem. J., 2003, 372, 725-734.
89. Blobel, C.P.; White, J.M. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr. Opin. Cell. Biol., 1992, 4, 760-765.
90. Wermelinger, L.; Geraldo, R.; Frattani, F.; Rodrigues, C.R.; Juliano, M.A.; Castro, H.C.; Zingali, R.B. Integrin inhibitors from snake venoms: Exploring the relationship between the structure and activity of RGD-peptides. Arch. Biochem. Biophys., 2009, 482, 25-32.
91. Moiseeva, N.; Bau, R.; Swenson, S.D.; Markland, F.S.; Choe, J.Y.; Liu, Z.J.; Allaire, M. Structure of acostatin, a dimeric disintegrins from Southern cooperhead (Agkistrodon contortrix contortrix) at 1.7 A resolution. Acta Crystallogr. D. Biol. Crystallogr., 2008, 64, 466-470.
92. Zha, H-G.; Lee, W-H.; Zhang, Y. Cloning of cDNAs encoding Ctype lectins from Elapidae snakes Bungarus fasciatus and Bungarus multicinctus. Toxicon, 2001, 39, 1887-1892.
93. Zingali, R.; Correa-Netto, C.; Guimaraes-Gomes, V. Snake venom C-type lectins and C-type lectins-like proteins. In Animal Toxins: State of the Art. Perspectives in Health and Biotechnology; de Lima, M.E., Pimenta, A.M.C., Martin-Euclaire, M.F., Zingalli, R.B., Rochat, H., Eds.; Editora UFMG: Belo Horizonte, 2009; pp. 589-606.
94. Lomonte, B.; Rojas, G.; Gutiérrez, J.M.; Ramírez, G. Isolation of a galactose-binding lectin from the venom of the snake Bothrops godmani (Godmanńs pit viper). Toxicon, 1990, 28, 75-81.
95. Nikai, T.; Kato, S.; Komori, Y.; Sugihara, H. Amino acid sequence and biological properties of the lectin from the venom of Trimeresurus okinavensis (Himehabu). Toxicon, 2000, 38: 707-711.
96. Guimaraes-Gomes, V.; Oliveira-Carvalho, A.; Junqueira-de-Azevedo, I.; Dutra, D.L.; Pujol-Luz, M.; Castro, H.C.; Ho, P.L.; Zingali, R.B. Cloning, characterization and structural analysis of a C-type lectin from Bothrops insularis (BiL) venom. Arch. Biochem. Biophys. 2004, 432, 1-11.
97. Lu, Q.; Navdaev, A.; Clemetson, J.; Clemetson, K. Snake venom C-type lectins interacting with platelet receptors.Structure-function relationships and effects on haemostasis. Toxicon, 2005, 45,1089-1098.
98. Kilpatrick, D.C. Animal lectins: a historical introduction and overview. Biochim. Biophys. Acta, 2002, 1572,187-197.
99. Álvarez, P.; Girao, M.; Rangel, C.; Carla, H. Structure-function inferences based on molecular modeling, sequence-based methods and biological data analysis of snake venom lectins. Toxicon, 2006, 48, 690-701.
100. Hedge, R.P.; Rajagopalan, N.; Doley, R.; Kini, R.M. Snake venom three-finger toxins. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P. Ed.; CRC Press: Boca Raton, 2009; pp. 287-301.
101. Bdolah, A. Sarafotoxins, the snake venom homologs of endothelins. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P. Ed.; CRC Press: Boca Raton, 2009, 303-315.
102. Heyborne, W.H.; Mackessy, S.P. Cysteine-rich secretory proteins in reptile venoms. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P. Ed.; CRC Press: Boca Raton, 2009, 325-336.
103. Harvey, A.L. Fasciculins. Toxins from mamba venoms that inhibit acetylcholinesterase. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P. Ed.; CRC Press: Boca Raton, 2009, 317-324.
104. Angulo, Y.; Estrada, R.; Gutiérrez, J.M. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom. Toxicon, 1997, 35, 81-90.
105. Moroz, C.; Goldblum, N.; Vries, A. Preparation of Vipera palestinae antineurotoxin using caroximethyl-cellulose-bound neurotoxin as antigen. Nature, 1963, 16, 697-698.
106. Kocholaty, W. Detoxification of Crotalus atrox venom by photooxidation in the presence of methylene blue. Toxicon, 1966, 3, 175-186.
107. Kocholaty, W.; Ashley, B. Detoxification of Russell's viper (Vipera russelli) and water moccasin (Agkistrodon piscivorus) venoms by photooxidation. Toxicon, 1966, 3, 187-194.
108. Higashi, H.G.; Guidolin, R.; Nishikawa, A.K.; Yamaguchi, I.K.; Lima, M.L.S.R.; Morais, J.F.; Dias Da Silva, W. Bothropic venoms pre-treated with inhibitors for active enzymatic sites of proteases and chelating substances preserve their immunogenicity. Mem. Inst. Butantan, 1989, 51, 107-115.
109. León, G.; Estrada, R.; Chaves, F.; Rojas, G.; Ovadia, M.; Gutiérrez, J.M. Inhibition by CaNa2EDTA of local tissue damage induced by Bothrops asper (terciopelo) venom: Application in horse immunization for antivenom production. Toxicon, 1998, 36, 321-331.
110. Grasset, E. Anavenoms and their use in the preparation of antivenomous sera. Trans. Royal. Soc. Trop. Med., 1945, 38, 463-488.
111. Costa, L. Comparative study of equine immune response towards venom from Crotalus durissus terrificus, in natura, treated with formaldehyde and submited to heat treatment. Vac. Soros, 1985, 1, 24-29.
112. Heneine, L; Cardoso, V.; Daniel, J.; Heneine, I.F. Detoxification of the T z fraction from a scorpion (Tityus serrulatus, Lutz and Mello) venom by iodination and some immunogenic properties of derivates. Toxicon, 1986, 24, 501-505.
113. Daniel, J.; Heneine, L.; Tavares, C.; Nascimento, M.C.; Heneine, I.F. Generation of protective immune sera by Crotalus durissus terrificus detoxified by controlled iodination. Braz. J. Med. Biol. Res., 1987, 20, 713-720.
114. Guidolin, R.; Dias da Silva, W.; Higashi, H.; Caricat, C.P.; Lima, M.L.S.R.; Morais, J.F.; Pinto, J.R.; Marcelino, J.R. Hyperimmunization of horses with bothropic and crotalic venoms treated with glutaraldehyde. Mem. Inst. Butantan, 1989, 51, 85-90.
115. Sawai, Y.; Kawamura, Y. Study on the toxoids against the venoms of certain Asian snakes. Toxicon, 1969, 7, 19-24.
116. Flowers, H. The effects of X-irradiation on the biological activity of cottonmouth moccasin (Ancistrodon piscivorus) venom. Toxicon, 1963, 1, 131-136.
117. Tejasen, P.; Ottolenghi, A. The effect of ultra-violet light on the toxicity and the enzymatic and antigenic activities of snake venom. Toxicon, 1970, 8, 225-230.
118. Rangel-Santos, A.C.; Mota, I. Effect of heating on the toxic, immunogenic and immunosuppressive activities of Crotalus durissus terrificus venom. Toxicon, 2000, 38, 1451-1457.
119. Hati, R.; Mandal, M.; Hati, K. Active immunization of rabbit with gamma irradiated russell's viper venom toxoid. Toxicon, 1990, 28, 895-902.
120. 60Co irradiated crotoxin in tissues of CBA/J mice. Nat. Toxins, 1998, 6, 19-25.
121. Clissa, P.B., do Nascimento N, Rogero JR. Toxicity and immunogenicity of Crotalus durissus terrificus venom treated with different doses of gamma rays. Toxicon, 1999, 37, 1131-1141.
122. Nascimento, N.; Seebart, C.; Francis, B.; Rogero, J.R.; Kaiser, I.I. Influence of ionizing radiation on crotoxin: biochemical and immunological aspects. Toxicon, 1996, 34, 123-131.
123. Sousa, J.R.F.; Monteiro, R.Q.; Castro, H.C.; Zingali, R.B. Proteolytic action of Bothrops jararaca venom upon its own constituents. Toxicon, 2001, 39, 787-792.
124. Medeiros, C.R.; Barbaro, K.C.; Lira, M.S.; França, F.O.; Zaher, V.L.; Kokron, C.M.; Kalil, J.; Castro, F.F. Predictors of Bothrops jararaca venom allergy in snake handlers and snake venom handlers. Toxicon, 2008, 51, 672-680.
125. Theakston, R.D.G.; Pugh, R.N.H.; Reid, H.A. Enzyme-lynked immunosorbent assay of venom antibodies in human victims of snakebite. J. Trop. Med. Hyg., 1981, 84, 109-122.
126. Ameno, S.; Ameno, K.; Fuke, Ch.; Kiryu, T.; Ljiri, I. IgG subclass distributions of anti-horse serum antibodies and natural venomantibodies produced in reponse to antivenom injection of snake bite in humans. Toxicon, 1990, 28, 347-350.
127. Domingos, M.O.; Cardoso, J.L.; Moura-da-Silva, A.M.; Mota, I. The humoral immune responses of patients bitten by the snake Bothrops jararaca (Jararaca). Toxicon, 1990, 28, 723-726.
128. Isbister, G.K.; Halkidis, L.; O'Leary, M.A.; Whitaker, R.; Cullen, P.; Mulcahy, R.; Bonnin, R.; Brown, S.G. Human anti-snake venom IgG antibodies in a previously bitten snake-handler, but no protection against local envenoming. Toxicon, 2009, 55, 646-649.
129. Chotwiwatthanakun, Ch.; Ronachai, P.; Akesowan, S.; Sriprapat, S.; Ratanabanangkoon, K. Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol. Toxicon, 2001, 39, 1487-1494.
130. Sriprapat, S.; Aeksowan, S.; Sapsutthipas, S.; Chotwiwatthanakun, C.; Suttijitpaisal, P.; Pratanaphon, R.; Khow, O.; Sitprija, V.; Ratanabanangkoon, K. The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand. Toxicon, 2003, 41, 57-64.
131. Harrison, R.A.; Hasson, S.S.; Harmsen, M.; Laing, G.D.; Conrath, K.; Theakston, R.D. Neutralization of venom-induced haemorrhage by IgG from camels and llamas immunized with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon, 2006, 47, 364-368.
132. El-Kady, E.M.; Ibrahim, N.M.; Wahby, A.F. Assessment of the anti-Naja haje antibodies elicited in a low dose multi-site immunization protocol. Toxicon, 2009, 54, 450-459.
133. Maya, C.; Vasantha, M.; Krishnan, L.K. Development of vipervenom antibodies in chicken egg yolk and assay of their antigen binding capacity. Toxicon, 2002, 40, 857-861.
134. Paul, K.; Manjula, J.; Deepa, E.P.; Selvanayagam, Z.E.; Ganesh, K.A.; Subba Rao, P.V. Anti-Echis carinatus venom antibodies from chicken egg yolk: Isolation, purification and neutralization efficacy. Toxicon, 2007, 50, 893-900.
135. New, R.; Theakston, R.; Zumbuehl, O.; Iddon, D.; Friend, J. Liposomal immunization against snake venoms. Toxicon, 1985, 23, 215-219.
136. Laing, G.; Theakston, R. Immunization against Echis ocellatus (carpet viper) venom using liposomes incorporating immunostimulants: role of lipopolysacharide in conferring protection in a mouse model. Toxicon, 1993, 31, 615-626.
137. 125I-labelled Walterinnesia aegyptia venom and its specific antivenins: flash absorption and distribution of the venom and its toxin versus slow absorption and distribution of IgG, F(ab')2 and F(ab) of the antivenin. Toxicon, 1998, 36, 93-114.
138. Riviére, G.; Choumet, V.; Saliou, B.; Debray, M.; Bon, C. Absorption and elimination of viper venom after antivenom administration. J. Pharmacol. Exp. Ther., 1998, 285, 490-495.
139. Lofthouse, Sh. Immunological aspects of controlled antigen delivery. Adv. Drug Deliv. Rev., 2002, 54, 863-870.
140. Teixeira, C.; Cury, Y.; Moreira, V.; Picolob, G.; Chaves, F. Inflammation induced by Bothrops asper venom. Toxicon, 2009, 54, 988-997.
141. Teixeira, C.F.P.; Landucci, E.C.T.; Antunes, E.; Chacur, M.; Cury, Y. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon, 2003, 42, 947-962.
142. Farsky, S.H.P.; Antunes, E.; Mello, S.B. Pro and anti-inflammatory properties of toxins from animal venoms. Curr. Durg Targets Imflamm. Allergy, 2005, 4, 401-411.
143. Costa, E.P.; Clissa, P.B.; Teixeira, C.F.P.; Moura da Silva, A.M. Importance of metalloproteinases and macrophages in viper snake envenomation-induced local inflammation. Inflammation, 2002, 26, 13-17.
144. Farsky, S.H.P.; Gonçalves, L.R.C.; Gutiérrez, J.M.; Correa, A.P.; Rucavado, A.; Gasque, P. Tambourgi, D.V. Bothrops asper snake venom and its metalloproteinase BaP-1 activate the complement system. Role in leucocyte recruitment. Med. Inflammation, 2000, 9, 213-221.
145. Rodrigues, F.G.; Petretski, J.H.; Kanashiro, M.M.; Lemos, L.; da Silva, W.D.; Kipnis, T.L. The complement system is involved in acute inflammation but not in the hemorrhage produced by a Bothrops atrox snake venom low molecular mass proteinase. Mol. Immunol., 2004, 40, 1149-1156.
146. Domont, G.B.; Perales, J.; Moussatche, H. Natural anti-snake venom proteins. Toxicon, 1991, 29, 1183-1194.
147. León, G.; Stiles, B.; Alape, A.; Rojas, G.; Gutiérrez, J.M. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom. Am. J. Trop. Med. Hyg., 1999, 62, 266-272.
148. León, G.; Monge, M.; Rojas, E.; Lomonte, B.; Gutiérrez, J.M. Comparison between IgG and F(ab')2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon, 2001, 39, 793-801.
149. Battellino, C.; Piazza, R.; Moura-da-Silva, A.M.; Cury, Y.; Farsky, S.H. Assesment of efficacy of bothropic antivenom therapy on microcirculatory effects induced by Bothrops jararaca snake venom. Toxicon, 2003, 41, 583-593.
150. Escalante, T.; Rucavado, A.; Pinto, A.F.; Terra, R.M.; Gutiérrez, J.M.; Fox, J.W. Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J. Prot. Res., 2009, 8, 5120-5131.
151. Zamunér, S.R.; Zuliani, J.P.; Fernandes, C.M.; Gutiérrez, J.M.; de Fátima-Pereira-Teixeira, C. Inflamation induced by Bothrops asper venom: release of proinflamatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration. Toxicon, 2005, 46, 806-813.
152. Gutiérrez, J.M.; Chaves, F.; Cerdas, L. Inflammatory infiltrate in skeletal muscle injected with Bothrops asper venom. Rev. Biol. Trop., 1986, 34, 209-219.
153. Lomonte, B.; Tarkowski, A.; Hanson, L.A. Host response to Bothrops asper snake venom. Inflammation, 1993, 17(2), 93-105.
154. Teixeira, C.F.; Zamunér, S.R.; Zuliani, J.P.; Fernandes, C.M.; Cruz-Hofling, M.A.; Fernandes, I.; Chaves, F.; Gutiérrez, J.M. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve, 2003, 28(4), 449-459.
155. Zamunér, S.R.; Gutiérrez, J.M.; Muscará, M.N.; Teixeira, S.A.; Teixeira, C.F. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon, 2001, 39(10), 1505-1513.
156. Dudziak, D.; Kamphorst, A.O.; Heidkamp, G.F.; Buchholz, V.R.; Trumpfheller, C.; Yamazaki, S.; Cheong, C.; Liu, K.; Lee, H.W.; Park, C.G.; Steinman, R.M.; Nussenzweig, M.C. Differential antigen processing by dendritic cell subsets in vivo. Science, 2007, 315(5808), 107-111.
157. Moura-da-Silva, A.M.; Laing, G.D.; Paine, M.J.; Dennison, J.M.; Politi, V.; Crampton, J.M.; Theakston, R.D. Processing of protumor necrosis factor-α by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite. Eur. J. Immunol., 1996, 26(9), 2000-2005.
158. Gutiérrez, J.M.; Rucavado, A.; Chaves, F.; Díaz, C.; Escalante, T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom. Toxicon, 2009, 54(7), 958-975.
159. Trevett, A.J.; Lallo, D.G.; Nwokolo, N.C.; Theakston, D.G.; Naraqi, S.; Warrell, D.A. Venom detection kits in the management of snakebite in central province, Papua New Guinea. Toxicon, 1995, 33(5), 703-705.
160. Selvanayagam, Z.E.; Gnanavendhan, S.G.; Ganesh, K.A.; Rajagopal, D.; Rao, P.V. ELISA for the detection of venoms from four medically important snakes of India. Toxicon, 1999, 37(5), 757-770.
161. van Dong, L.; Quyen le, K.; Eng, K.H.; Gopalakrishnakone, P. Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection. J. Immunol. Meth., 2003, 282(1-2), 13-31.
162. Moreno, E.; Gutiérrez, J.M. Body distribution of Bothrops asper (Terciopelo) snake venom myotoxin and its relationship to pathological changes. Toxicon, 1988, 26(4), 403-409.
163. Metlay, J.P.; Puré, E.; Steinman, R.M. Control of the immune response at the level of antigen-presenting cells: A comparison of the function of dendritic cells and B lymphocytes. Adv. Immunol., 1989, 47, 45-116.
164. Rodríguez-Pinto, D. B cells as antigen presenting cells. Cell. Immunol., 2005, 238(2), 67-75.
165. Thai, R.; Moine, G.; Desmadril, M.; Servent, D.; Tarride, J.L.; Ménez, A.; Léonetti, M. Antigen stability controls antigen presentation. J. Biol. Chem., 2004, 279(48), 50257-50266.
166. Cardoso, D.F.; Mota, I. Effect of Crotalus venom on the humoral and cellular immune response. Toxicon, 1997, 35(4), 607-612.
167. Cruz, A.H.; Mendonça, R.Z.; Petricevich, V.L. Crotalus durissus terrificus venom interferes with morphological, functional, and biochemical changes in murine macrophage. Mediat. Inflamm., 2005, 2005(6), 349-359.
168. Zuliani, J.P.; Gutiérrez, J.M.; Cassais-e-Silva, L.L.; Coccuzzo-Sampaio, S.; Lomonte, B.; Pereira-Teixeira, Cde.F. Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A2. Toxicon, 2005, 46(5), 523-532.
169. Sampaio, S.C.; Brigatte, P.; Sousa-e-Silva, M.C.; dos-Santos, E.C.; Rangel-Santos, A.C.; Curi, R.; Cury, Y. Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. Toxicon, 2003, 41(7), 899-907.
170. Rangel-Santos, A.; Lima, C.; Lopes-Ferreira, M.; Cardoso, D.F. Immunosuppresive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom. Toxicon, 2004, 44(6), 609-616.
171. Sampaio, S.C.; Rangel-Santos, A.C.; Peres, C.M.; Curi, R.; Cury, Y. Inhibitory effect of phospholipase A2 isolated from Crotalus durissus terrificus venom on macrophage function. Toxicon, 2005, 45(5), 671-676.
172. Skok, M.V.; Kalashnik, E.N.; Koval, L.N.; Tsetlin, V.I.; Utkin, Y.N.; Changeux, J.P.; Grailhe, R. Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol. Pharmacol., 2003, 64(4), 885-889.
173. Skok, M.; Grailhe, R.; Changeux, J.P. Nicotinic receptors regulate B lymphocyte activation and immune response. Eur. J. Pharmacol., 2005, 517(3), 246-251.
174. Estrada, R.; Robles, A.; Alvarado, J.; Rojas, E.; Gonzalez, N.; Segura, E.; Gutiérrez, J.M. Development of antibody response and clinical and hematological alterations in horses immunized with snake venoms for the production of antivenom in Costa Rica. Mem. Inst. Butantan, 1991, 53(2), 181-190.
175. Waghmare, A.; Deopurkar, R.L.; Salvi, N.; Khadilkar, M.; Kalolikar, M.; Gade, S.K. Comparisson of Montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom. Vaccine, 2009, 27(7), 1067-1072.
176. Heyman, B. Feedback regulation by IgG antibodies. Immunol. Lett., 2003, 88(2), 157-161.
177. Brady, L.J. Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens. Infect. Immun., 2005, 73(2), 671-678.
178. Minton, S.A., Jr. Paraspecific protection by elapid and sea snake antivenins. Toxicon, 1967, 5(1), 47-55.
179. Minton, S.A. Neutralization of old world vipers venoms by American pit viper antivenin. Toxicon, 1976, 14(2), 146-148.
180. Chippaux, J.P.; Williams, V.; White, J. Snake venom variability: methods of study, results and interpretation. Toxicon, 1991, 29(11), 1279-1303.
181. Ferreira, M.; Moura-Da-Silva, A.M.; Mota, I. Neutralization of different activities of venoms from nine species of Bothrops snakes by Bothrops jararaca antivenom. Toxicon, 1992, 30(12), 1591-1602.
182. Dias da Silva, W.; Guidolin, R.; Raw, I.; Higashi, H.G.; Caricatti, C.P.; Morais J.F.; Lima, M.L.; Yamaguchi, I.K.; Nishikawa, A.K., Stephano, M.N.; Marcelino, J.R.; Pinto, J.R.; Santos, M.J. Crossreactivity of horse monovalent antivenoms to venom of ten Bothrops species. Mem Inst Butantan, 1989, 51, 153-168.
183. Anderson, S.; Gutiérrez, J.M.; Ownby, C.L. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms. Toxicon, 1993, 31(8), 1051-1059.
184. Arce, V.; Rojas, E.; Ownby, C.L.; Rojas, G.; Gutiérrez, J.M. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Toxicon, 2003, 41(7), 851-860.
185. Ramos-Cerrillo, B.; de Roodt, A.; Chippaux, J.P.; Olguín, L.; Casasola, A.; Guzmán, G.; Paniagua-Solís, J.; Alagón, A.; Stock, R.P. Characterization of a new polyvalent antivenom (Antivipmyn® Africa) against African vipers and elapids. Toxicon, 2008, 52(8), 881-888.
186. Casasola, A.; Ramos-Cerrillo, B.; de Roodt, A.; Carbajal Saucedo, A.; Chippaux, J.P.; Alagón, A.; Stock, R.P. Paraspecific neutralization of the venom of African species of cobra by analysis of equine antiserum against Naja melanoleuca: A comparative study. Toxicon, 2009, 53(6), 602-608.
187. Segura, A.; Villalta, M.; Herrera, M.; León, G.; Harrison, R.; Durfa, N.; Nasidi, A.; Calvete, J.J.; Theakston, R.D.; Warrell, D.A.; Gutiérrez, J.M. Preclinical assesment of the efficacy of a new antivenom (EchiTab-Plus-ICP®) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon, 2010, 55(2/3), 369-374.
188. Ownby, C.; Colberg, T. Comparison of the immunogenicity and antigenic composition of several venoms of snakes in the family Crotalidae. Toxicon, 1990, 28, 189-199.
189. Kornalík, F.; Táborská, E. Cross reactivity of mono and polyvalent antivenoms with viperidae and crotalidae snake. Toxicon, 1989, 27(10), 1135-1142.
190. Nair, C.; Nair, B.; Elliot, W.B. Immunological comparison of Phospholipases A2 present in rattlesnake (genus Crotalus) venoms. Toxicon, 1980, 18(5/6), 675-680.
191. Bolaños, R.; Cerdas, L.; Taylor, R. The production and characteristics of a coral snake (Micururs mipartitus hertwigi) antivenin. Toxicon, 1975, 13(2), 139-142.
192. Chinonavanig, L.; Billings, P.B.; Matangkasombut, P.; Ratanabanangkoon, K. Antigenic relationships and relative immunogenicities of venom proteins from six poisonous snakes of Thaliand. Toxicon, 1988, 26(9), 883-890.
193. Gutiérrez, J.M.; Lomonte, B.; León, G.; Alape-Girón, A.; Flores-Díaz, M.; Sanz, L.; Angulo, Y.; Calvete, J.J. Snake venomics and antivenomics: Proteomic Tools in the design and control of antivenoms for the treatment of snakebite envenoming. J. Prot., 2009, 72(2), 165-182.
194. White, J. Envenomation. Prevention and treatment in Australia. In: Handbook of Venoms and Toxins of Reptiles; Mackessy, S.P., Ed.; CRC Press: Boca Raton, 2009; pp. 423-451.
195. Stills, H.F., Jr. Adjuvants and antibody production: dispelling the myths associated with Freud's complete and other adjuvants. ILAR J., 2005, 46(3), 280-293.
196. Jennings, V.M. Review of selected adjuvants used in antibody production. ILAR J., 1995, 37(3), 119-125.
197. Morais, V.; Massaldi, H. Economic evaluation of snake antivenom production in the public system. J. Venom. Anim. Toxins incl. Trop. Dis., 2006, 12(3), 497-511.
198. Gregoriadis, G. Immunological adjuvants: a role for liposomes. Immunol. Today, 1990, 11(3), 89-97.
199. Bowersock, T.L.; Martin, S. Vaccine delivery to animals. Adv. Drug. Deliv. Rev., 1999, 38(2), 167-194.
200. Sadahiro, S.; Kondo, L.; Yamamoto, A. Effects of adjuvants on the immunogenicity of Habu-venom toxoid in the monkey and the guinea pig. Jpn. J. Med. Sci. Biol., 1981, 34(3), 169-173.
201. Freitas, T.V.; Fortes-Dias, C.L.; Diniz, C.R.; Velarde, D.T.; Freitas, C.F. Immunization of horses with Crotalus durissus terrificus (south American rattlesnake) venom. A comparison of four different procedures. Braz. J. Med. Biol. Res., 1991, 24(3), 281-290.
202. Sunthornandh, P.; Ratanabanangkoon, K. A comparative study of three vehicles on antibody responses against elapid snake neurotoxin immunogens. Toxicon, 1994, 32(5), 561-571.
203. Lindblad, E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine, 2004, 22(27/28), 3658-3668.
204. Pratanaphon, R.; Akesowan, S.; Khow, O.; Sriprapat, S.; Ratanabanangkoon, K. Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia). Vaccine, 1997, 15(14), 1523-1528.
205. Theakston, R.D.G.; Zumbuehl, O.; New, R.R.C. Use of liposomes for protective immunization in sheep against Equis carinatus snake venom. Toxicon, 1985, 23(6), 921-925.
206. Carvalho, V.T.; Gomes, R.T.; Viotti, A.P.; Freitas, T.V. Immunization with liposome-encapsulated Bothrops jararaca venom. Toxicon, 2000, 38(6), 881-886.
207. Freitas, T.V; Tavares, A.P.; Theakston, R.D.; Laing, G.; New, R.R. Use of liposomes for protective immunisation against Crotalus durissus (tropical rattlesnake) venom. Toxicon, 1989, 27(3), 341-347.
208. Freitas, T.V.; Frézard, F. Encapsulation of native crotoxin in liposomes: a safe approach for the production of antivenom and vaccination against Crotalus durissus terrificus venom. Toxicon, 1997, 35(1), 91-100.
209. Alam, M.I.; Gomes, A. Adjuvant effects and antiserum action potentiation by a (herbal) compound 2-hydroxy-4-methoxy benzoic acid isolated from the root extract of the indian medicinal plant "sarsaparilla" (Hemidesmus indicus r. br.). Toxicon, 1998, 36(10), 1423-1431.
210. Chaves, F.; Chacón, M.; Badilla, B.; Arévalo, C. Effect of Echinacea purpurea (Asteraceae) aqueous extract on antibody response to Bothrops asper venom and immune cell response. Rev. Biol. Trop., 2007, 55(1), 113-119.
211. Judge, R.K.; Henry, P.J.; Mirtschin, P.; Jelinek, G.; Wilce, J.A. Toxins not neutralized by brown snake antivenom. Toxicol. Appl. Pharmacol., 2006, 213(2), 117-125.
212. Soares, A.M.; Sestito, W.P.; Marcussi, S.; Stábeli, R.G.; Andrião-Escarso, S.H.; Cunha, O.A.; Vieira, C.A.; Giglio, J.R. Alkylation of myotoxic phospholipases A2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production. Int. J. Biochem. Cell Biol., 2004, 36(2), 258-270.
213. Sewall, H. Experiments on the preventive inoculation of rattlesnake venom. J. Physiol., 1887, 8(3-4), 203-210.
214. Sawai, Y. A study on the prophylactic toxoid against venom of Asian snakes. Final report, N° FE-356-2. Contract No. DAJB17- 67-C-0610, U.S. Army Research and Development Group (Far East) 1968; http://www.normanbenoit.com/Habu%20project.pdf.pdf.
215. Sadahiro, S.; Kondo, S.; Kondo, H.; Ohsaka, A.; Fukushima, H.; Murata, R. Standardization of habu (Trimeresurus flavoviridis) snake-venom toxoid. Toxicon, 1978, 16(3), 275-282.
216. Gutiérrez, J.M.; León, G.; Rojas, G.; Lomonte, B.; Rucavado, A.; Chaves, F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon, 1998, 36(11), 1529-1538.
217. Rucavado, A.; Lomonte, B. Neutralization of myonecrosis, hemorrhage and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. Toxicon, 1996, 34(5), 567-577.
218. Chippaux, J.; Goyffon, M. Production and use in snake antivenin. In: Handbook of Natural Toxins; Tu, A.T. Ed.; Marcel Dekker: New York, 1991, pp 529-555.
219. Warrell, D.A. Geographical and intraspecies variation in the clinical manifestations of envenoming by snakes. In: Venomous Snakes. Ecology, Evolution and Snakebite; Thorpe, R.S., Wüster, W., Melhotra, A. Eds.; Clarendon Press: Oxford, 1997, pp. 189-203.
220. Fry, B.G.; Winkel, K.D.; Wickramaratna, J.C.; Hodgson, W.C.; Wuster, W. Effectiveness of snake antivenom: species and regional venom variation and its clinical impact. J. Toxicol. Toxin. Rev., 2003, 22(1), 23-34.
221. Camey, K.U.; Velarde, D.T.; Sanchez, E.F. Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil. Toxicon, 2002, 40(5), 501-509.
222. Raweerith, R.; Ratanabanangkoon, K. Immunochemical and biochemical comparisons of equine monovalent and polyvalent snake antivenoms. Toxicon, 2005, 45(3), 369-375.
223. Stephano, M.A.; Guidolin, R.; Higashi, H.G.; Higashi, H.G.; Tambourgi, D.V.; Sant'Anna, O.A. The improvement of the therapeutic anti-Lachesis muta serum production in horses. Toxicon, 2005, 45(4), 467-473.
224. Harrison, R.A. Development of venom toxin-specific antibodies by DNA immunization: rationale and strategies to improve therapy of viper envenoming. Vaccine, 2004, 22(13/14), 1648-1655.
225. Wagstaff, S.C.; Laing, G.D.; Theakston, R.D.G.; Papaspyridis, C.; Harrison, R.A. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom. PLoS Med, [On Line] 2006, 3(6), 832-844. http://plosmedicine.org/ [Accessed on: 06 June 2006].
226. Harrison, R.A.; Moura-da-Silva, A.M.; Laing, G.D.; Wu, Y.; Richards, A.; Broadhead, A.; Bianco, A.E.; Theakston, R.D. Antibody from mice immunized with DNA enconded the carboxildisintegrin and cysteine-rich domain (jD9) of the haemorrhagic metalloproteinase, jararhagin, inhibits the main lethal component of viper venom. Clin Exp Immunol, 2000, 121(2), 358-363.
227. Arce-Estrada, V.; Azofeifa-Cordero, G.; Estrada, R.; Alape-Girón, A.; Flores-Díaz, M. Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper. Vaccine, 2009, 27(3), 460-466.
228. Azofeifa-Cordero, G.; Arce-Estrada, V.; Flores-Díaz, M.; Alape-Girón, A. Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom. Toxicon, 2008, 52(2), 302-308.
229. Pergolizzi, R.G.; Dragos, R.; Ropper, A.E.; Menez, A.; Crystal, R.G. Protective immunity against a-cobratoxin following a single administration of a genetic vaccine encoding a non-toxic cobratoxin variant. Hum. Gene. Ther., 2005, 16(3), 292-298.
230. Gutiérrez, J.M.; Chaves, F.; Rojas, E.; Elizondo, J.; Avila, C.; Cerdas, L. Production of monovalent anti-Bothrops asper antivenom: development of immune response in horses and neutralizing ability. Rev. Biol. Trop., 1988, 36(2B), 511-517.
231. Estrada, R.; Gutiérrez, J.M.; Alvarado, J.; Robles, A.; Avila, C.; Gonzáles, N. Desarrollo de la respuesta de anticuerpos antifosfolipasa A2 en caballos inoculados con veneno para la producción de suero antiofídico polivalente en Costa Rica. Rev. Biol. Trop., 1989, 37(2), 187-191.
232. Christensen, P.A. South African Snake Venoms and Antivenoms; The South African Institute for Medical Research: Johannesburg, 1955, pp. 52-57.
233. Russell, F.; Timmerman, W.; Meadows, P. Clinical use of antivenin prepared from goat serum. Toxicon, 1970, 8(1), 63-65.
234. Fernández, G.P.; Segura, A.; Herrera, M.; Velasco, W.; Solano, G.; Gutiérrez, J.M.; León, G. Neutralization of Bothrops mattogrossensis snake venom from Bolivia: Experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation. Toxicon, 2009, 55(2/3), 642-645.
235. Helms, C.M.; Allen, P.Z. Studies on equine immunoglobulins. II. Antigenic interrelationships among horse IgG, IgG(T) and antipneumococcal 1 component. J. Immunol., 1970, 105(5), 1253-1263.
236. Widders, P.; Stokes, C.R.; Bourne, F.J. Investigation of the antigenic relationship between equine IgG and IgGT. Vet. Imm. Imm., 1986, 13(3), 255-259.
237. Fernandes, I.; Takehara, H.A.; Mota, I. Isolation of IgGT from hyperimmune horse anti-snake venom serum: its protective ability. Toxicon, 1991, 29(11), 1373-1379.
238. Fernandes, I.; Takehara, H.A.; Santos, A.C.; Cormont, F.; Latinne, D.; Barzin, H.; Mota, I. Neutralizing of bothropic and crotalic venom toxic activities by IgG(T) and IgGa subclasses isolated from immune horse serum. Toxicon, 1997, 35(6), 931-936.
239. Fernandes, I.; Tavares, F.L.; Sano-Martins, I.S.; Takehara, H.A. Efficacy of bothropic antivenom and its IgG (T) fraction in restoring fibrinogen levels of Bothrops jararca envenomed mice. Toxicon, 2000, 38(7), 995-998.
240. 2 antivenoms. An example: New polyvalent european viper antivenom (equine). In: Envenomings and Their Treatments; Bon, C., Goyffon, M. Eds.; Editions Fondation Marcel Merieux: Lyon, 1996, pp. 161-172.
241. Wagner, B. Immunoglobulins and immunoglobulin genes of the horse. Devel. Comp. Immunol., 2006, 30(1-2), 155-164.
242. Sjostrom, L.; AL-Abdulla, I.H.; Rawat, S.; Smith, D.C.; Landon, J. A comparison of ovine and equine antivenoms. Toxicon, 1994, 32(4), 427-433.
243. Landon, J.; Smith, D.S. Merits of sheep antisera for antivenom manufacture. J. Toxicol. Toxin. Rev., 2003; 22(1), 15-22.
244. Herrera, M.; León, G.; Segura, A.; Meneses, F.; Lomonte, B.; Chippaux, J.P.; Gutiérrez, J.M. Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs. Toxicon, 2005, 46(7), 775-781.
245. Redwan, E.R.M.; Fahmy, A.; Hanafy, A.E.; EL-Baky, N.A. Ovine anti-rabies antibody production and evaluation. Comp. Immunol. Microbiol., 2009, 32(1), 9-19.
246. Hamers-Casterman, C.; Atarhouch, T.; Muyldermans, S.; Robinson, G.; Hamers, C.; Songa, E.B.; Bendahman, N.; Hamers, R. Naturally occurring antibodies devoid of light chains. Nature, 1993, 363(6428), 446-448.
247. Muyldermans, S.; Baral, T.; Retamozzo, V.C.; De Baetselier, P.; De Genst, E.; Kinne, J.; Leonhardt, H.; Magez, S.; Nguyen, V.K.; Revets, H.; Rothbauer, U.; Stijlemans, B.; Tillib, S.; Wernery, U.; Wyns, L.; Hassanzadeh-Ghassabeh, G.; Saerens, D. Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunop., 2009, 128(1/3), 178-183.
248. Meddeb-Mouelhi, F.; Bouhaouala-Zahar, B.; Benlasfar, Z.; Hammadi, M.; Mejri, T.; Moslah, M.; Karoui, H.; Khorchani, T.; El Ayeb, M. Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins. Toxicon, 2003, 42(7), 785-791.
249. de Simone, E.; Saccodossi, N.; Ferrari, A.; Leoni, L.; Leoni, J. Immunochemical analysis of IgG subclasses and IgM in South American camelids. Small Ruminant Res., 2006, 64(1/2), 2-9.
250. Almeida, C.M.; da Silva, C.L.; Couto, H.P.; Escocard, Rde. C.; da Rocha, D.G.; Sentinelli, Lde. P.; Kipnis, T.L.; da Silva, W.D. Development of process to produce polyvalent IgY antibodies anti-African snake venom. Toxicon, 2008, 52(2), 293-301.
251. Meenatchisundaram, S.; Parameswari, G.; Michael, A.; Ramalingam, S. Neutralization of the pharmacological effects of Cobra and Krait venoms by chicken egg yolk antibodies. Toxicon, 2008, 52(2), 221-227.
252. McLaren, R.D.; Prosser, C.G.; Grieve, R.C.; Borissenko, M. The use of caprylic acid for the extraction of the immunoglobulin fraction from egg yolk of chickens immunized with ovine alphalactalbumin. J. Immunol. Meth., 1994, 177(1-2), 175-184.
253. Almeida, C.M.; Kanashiro, M.M.; Rangel Filho, F.B.; Mata, M.F.; Kipnis, T.L.; da Silva, W.D. Development of snake antivenom antibodies in chickens and their purification from yolk. Vet. Rec., 1998, 143(21), 579-584.
254. Warr, G.W.; Magor, K.E.; Higgins, D.A. IgY: clues to the origins of modern antibodies. Immunol. Today, 1995, 16(8), 392-398.
255. Sevcik, C.; Díaz, P.; D'Suze, G. On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production. Toxicon, 2008, 51(1), 10-16.
256. Gutiérrez, J.M.; Rojas, G.; Lomonte, B.; Gené, J.A.; Chaves, F.; Alvarado, J.; Rojas, E. Standardization of assays for testing the neutralizing ability of antivenoms. Toxicon, 1990, 28(10), 1127-1129.
257. Bogarín, G.; Morais, J.F.; Yamaguchi, I.K.; Stephano, M.A.; Marcelino, J.R.; Nishikawa, A.K.; Guidolin, R.; Rojas, G.; Higashi, H.G.; Gutiérrez, J.M. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon, 2000, 38(10), 1429-1441.
258. Rojas, E.; Quesada, L.; Arce, V.; Lomonte, B.; Rojas, G.; Gutiérrez, J.M. Neutralization of four Peruvian Bothrops sp. Snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment. Acta Trop., 2005, 93(1), 85-95.
259. Araujo, H.P.; Bourguignon, S.C.; Boller, M.A.; Dias, A.A.; Lucas, E.P.; Santos, I.C.; Delgado, I.F. Potency evaluation of antivenoms in Brazil: The national control laboratory experience between 2000 and 2006. Toxicon, 2008, 51(4), 502-514.
260. Meier, J.; Theakston, R.D.G. Approximate LD50 determinations of snake venoms using eight to ten experimental animals. Toxicon, 1986, 24(4), 395-401.
261. Sells, P.G. Animal experimentation in snake venom research and in vitro alternatives. Toxicon, 2003, 42(2), 115-133.
262. Gutiérrez, J.M.; Avila, C.; Rojas, E.; Cerdas, L. An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon, 1988, 26(4), 411-413.
263. Pradhan, S.; Kumar, S.; Singh, D.; Sood, R.C.; Sehgal, R. Development of passive haemagglutination (PHA) an haemagglutination inhibition (HAI) technique for potency estimation of Cobra antisnake venom serum (ASVS). Biologicals, 2007, 35(3), 155-160.
264. Theakston, R.D.; Reid, H.A. Enzyme-linked immunosorbent assay (ELISA) in assessing antivenom potency. Toxicon, 1979, 17(5), 511-515.
265. Price, J.A.; Sanny, C.G. CroFabTM total anti-venom activity measured by SE-HPLC, and anti PLA2 activity assayed in vitro at physiological pH. Toxicon, 2007, 49(6), 848-854.
266. Heneine, L.G.; Carvalho, A.D.J.; Barbosa, C.F.; Arávio dos Santos, M.R. Development of an ELISA to assess the potency of horse therapeutic polyvalent antibothropic antivenom. Toxicon, 1998, 36(10), 1363-1370.
267. Maria, W.S.; Cambuy, M.O.; Costa, J.O.; Velarde, D.T.; Chávez-Olórtequi, C. Neutralizing potency of horse antibothropic antivenom. Correlation between in vivo and in vitro methods. Toxicon, 1998, 36(10), 1433-1439.
268. Rial, A.; Morais, V.; Rossi, S.; Massaldi, H. A new ELISA for determination of potency in snake antivenoms. Toxicon, 2007, 48(4), 462-466.
269. Alape-Girón, A.; Miranda-Arrieta, K.; Cortes-Bratti, X.; Stiles, B.G.; Gutiérrez, J.M. A comparison of in vitro methods for assessing the potency of therapeutic antisera against the venom of the coral snake Micrurus nigrocinctus. Toxicon, 1997, 35(4), 573-581.
270. Maria, W.S.; Pacheco, B.G.; Barbosa, C.F.; Velarde, D.T.; Chávez-Olórtequi, C. Determination of the neutralizing potency of horse antibothropic and anticrotalic antivenoms in blood samples collected on filter paper. Toxicon, 2001, 39(10), 1607-1609.
271. Judge, R.K.; Henry, P.J.; Mirtschin, P.; Jelinek, K.; Wilce, J.A. Toxins not neutralized by brown snake antivenom. Toxicol. Appl. Pharm., 2006, 213(2), 117-125.